These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3500131)

  • 1. The cellular immune response to a purified antigen from Leishmania mexicana subsp. amazonensis enhances the size of the leishmanial lesion on susceptible mice.
    Rodrigues MM; Mendonça-Previato L; Charlab R; Barcinski MA
    Infect Immun; 1987 Dec; 55(12):3142-8. PubMed ID: 3500131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cellular immune response to chemically defined glycoconjugates from Leishmania mexicana subsp. amazonensis.
    Rodrigues MM; Xavier MT; Previato LM; Barcinski MA
    Infect Immun; 1986 Jan; 51(1):80-6. PubMed ID: 2416692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.
    Liew FY; Singleton A; Cillari E; Howard JG
    J Immunol; 1985 Sep; 135(3):2102-7. PubMed ID: 3160786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections.
    Alexander J; Kaye PM
    Clin Exp Immunol; 1985 Sep; 61(3):674-82. PubMed ID: 3907906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic changes induced by vaccination in experimental cutaneous leishmaniasis of BALB/c mice.
    Barral-Netto M; de Freitas LA; Andrade ZA
    Am J Pathol; 1987 May; 127(2):271-8. PubMed ID: 3495185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 17-kilodalton Leishmania antigen revealed by immunochemical studies of a purified glycoprotein fraction recognized by murine T lymphocytes.
    Rodrigues MM; Xavier MT; Mendonça-Previato L; Barcinski MA
    Infect Immun; 1988 Jul; 56(7):1766-70. PubMed ID: 3260220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific immunization of mice against Leishmania mexicana amazonensis using solubilized promastigotes.
    Barral-Netto M; Reed SG; Sadigursky M; Sonnenfeld G
    Clin Exp Immunol; 1987 Jan; 67(1):11-9. PubMed ID: 2441913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activation of suppressor cells of the delayed hypersensitivity response in BALB/c mice infected or immunized with Leishmania mexicana pifanoi].
    Pérez HA; Henriquez M; de la Rosa M
    Mem Inst Oswaldo Cruz; 1985; 80(4):429-38. PubMed ID: 2943969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P; Pearce E; Natovitz P; Sher A
    J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
    Liew FY; Dhaliwal JS
    J Immunol; 1987 Jun; 138(12):4450-6. PubMed ID: 3295049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis.
    De Rossell RA; Bray RS; Alexander J
    Parasite Immunol; 1987 Jan; 9(1):105-15. PubMed ID: 3562057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY; Howard JG; Hale C
    J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Independence of the delayed hypersensitivity response from protection against Leishmania mexicana pifanoi].
    Pérez HA; De la Rora M
    Acta Cient Venez; 1986; 37(5):542-6. PubMed ID: 2966535
    [No Abstract]   [Full Text] [Related]  

  • 14. Differences in the lymphoproliferative pattern to Leishmania mexicana antigens recognized by immunized and infected mice.
    Correnti M; Ortega G
    Acta Trop; 1994 Dec; 58(3-4):243-53. PubMed ID: 7709863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.
    Coelho EA; Tavares CA; Carvalho FA; Chaves KF; Teixeira KN; Rodrigues RC; Charest H; Matlashewski G; Gazzinelli RT; Fernandes AP
    Infect Immun; 2003 Jul; 71(7):3988-94. PubMed ID: 12819086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis.
    Coler RN; Skeiky YA; Bernards K; Greeson K; Carter D; Cornellison CD; Modabber F; Campos-Neto A; Reed SG
    Infect Immun; 2002 Aug; 70(8):4215-25. PubMed ID: 12117930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response and protection in mice inoculated with Leishmania amazonensis clones expressing different degrees of virulence.
    da Fonseca AL; Vallochi AL; Furtado Gde C; Abrahamsohn Ide A; Lima GM
    Parasitol Res; 1997; 83(7):690-7. PubMed ID: 9272560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis.
    Pinto EF; de Mello Cortezia M; Rossi-Bergmann B
    Vaccine; 2003 Sep; 21(25-26):3534-41. PubMed ID: 12922080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis.
    Dhaliwal JS; Liew FY
    Infect Immun; 1987 Mar; 55(3):645-51. PubMed ID: 3818088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes.
    Russell DG; Alexander J
    J Immunol; 1988 Feb; 140(4):1274-9. PubMed ID: 3257774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.